1. Home
  2. EIG vs ODTX Comparison

EIG vs ODTX Comparison

Compare EIG & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$49.49

Market Cap

911.6M

Sector

Finance

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$21.17

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EIG
ODTX
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
911.6M
875.1M
IPO Year
2006
2026

Fundamental Metrics

Financial Performance
Metric
EIG
ODTX
Price
$49.49
$21.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
186.9K
227.2K
Earning Date
04-29-2026
N/A
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$858,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.26
N/A
P/E Ratio
$24.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$15.10
52 Week High
$52.59
$22.11

Technical Indicators

Market Signals
Indicator
EIG
ODTX
Relative Strength Index (RSI) 55.51 66.56
Support Level $48.30 $15.10
Resistance Level $52.32 N/A
Average True Range (ATR) 1.27 1.48
MACD -0.09 0.38
Stochastic Oscillator 54.93 89.04

Price Performance

Historical Comparison
EIG
ODTX

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: